Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024
After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its growing sterile injectables portfolio. But even with signs trending upward, Pfizer is preparing to exit an Australian site specializing in those drugs as part of a global reorganization effort.
Pfizer will walk away from its more than 50-year-old facility in Perth, Australia—and jeopardize 470 jobs—as the company undergoes a "thorough evaluation" of its global manufacturing chain, a Pfizer spokeswoman said Monday.
The New York-based drugmaker expects to wind down operations at the Perth site by the end of 2023 and fully exit the facility in the first quarter of 2024. The facility specializes in sterile injectable manufacturing and mostly supplies drugs to the Australian and New Zealand markets, according to Pfizer's website.
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Just Now, Pfizer's Blockbuster Small Molecule New Drug Paxlovid was Urgently Approved in China!
-
The Final Effective Rate Of Pfizer's Oral New Covid Drug Is 89%
-
Pfizer and BioNTech achieve Health Canada authorization for their vaccine to com
-
Pfizer and BioNTech announce publication of results from landmark Phase 3 trial
-
FDA expert panel recommends EUA for Pfizer/BioNTech COVID-19 vaccine
-
European Commission approves contract with BioNTech-Pfizer alliance
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
Two Major Chemical Companies Collapse in May as the Global Industry Faces a Broad Downturn
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
$14.5 Billion Solstice–Element Solutions Merger Abruptly Terminated Less Than Two Months After Announcement
Recommend Reading
-
![Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness]()
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
![COSMAX Acquires 51% Stake in Keminova, Establishes First European Production Base]()
COSMAX Acquires 51% Stake in Keminova, Establishes First European Production Base
-
![China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million]()
China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million
-
![A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant]()
A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant
-
![A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message]()
A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message
-
![Rising Raw Material Costs Drive Slight Increase in August Polyester Filament Market Prices]()
Rising Raw Material Costs Drive Slight Increase in August Polyester Filament Market Prices
-
![Urea Market Trends in February Show a Strong, Rising Trend]()
Urea Market Trends in February Show a Strong, Rising Trend
-
![This Week's Aniline Market Shows a Small Increase (11.17-11.21)]()
This Week's Aniline Market Shows a Small Increase (11.17-11.21)
-
![Business Society’s Market Outlook for Maleic Anhydride on August 27, 2026: Volatile]()
Business Society’s Market Outlook for Maleic Anhydride on August 27, 2026: Volatile
-
![Both Cost and Demand Weaken, PTA Prices Slightly Decline]()
Both Cost and Demand Weaken, PTA Prices Slightly Decline
